Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms

Inclusion Criteria: * Written informed consent to participate in the study. * Willingness to actively participate in the study and to come to the scheduled visits. * Female and/or male * From 18 to 85 years of age * Patients with self-reported abdominal bloating, abdominal distention, flatulence, and abdominal discomfort either after meals or not at least 3x a week for a minimum of the past 2 weeks Exclusion Criteria: * Drug addicts, alcoholics. * AIDS, HIV-positive or infectious hepatitis * Diabetes mellitus * Disorders known to affect GI motility such as gastroparesis or amyloidosis. * Disorders with GI symptoms such as irritable bowel syndrome, inflammatory bowel disease and celiac disease * History of surgery known to alter the normal function of the GI tract. * Conditions which exclude participation or might influence the test reaction/evaluation. * Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area. * Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years. * Documented allergies to cosmetic products and/or ingredients * Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) within the last 6 weeks prior to the start of the study and/or throughout the entire course of the study. * Oral steroids within the last 4 weeks prior to the start of the study and/or throughout the entire course of the study * Oral or systemic therapy with antibiotics within the last 3 months prior to the start of the study and/or throughout the entire course of the study * Subjects who were treated with biologics within the last 6 months prior to the start of the study and/or throughout the entire course of the study. * One of the following illnesses if not medicated: cardiovascular diseases, thyroid hyperfunction, asthma, hypertension.